Condition
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials that are recruiting, at sites in 2 countries (most in China (2), Italy (1)). By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| QH103 (universal CD19 CAR-γδT) cell injections for relapsed or treatment‑resistant antibody-driven neurological autoimmune diseases | Phase 1 | Wuhan, Hubei | Recruiting | Apr 13, 2026 |
| Nerve function and structure in CMT, anti‑MAG neuropathy, and CIDP | — | Milan | Recruiting | Mar 10, 2026 |
| CD19/BCMA-targeted UCAR-T for neurological autoimmune disorders | Early Phase 1 | Wuhan, Hubei | Recruiting | Jan 13, 2026 |
All recruiting trials (3)
-
QH103 (universal CD19 CAR-γδT) cell injections for relapsed or treatment‑resistant antibody-driven neurological autoimmune diseases
This Phase 1 test will see if QH103 (universal CD19 CAR-γδT) cell injections are safe and tolerated in adults with relapsed or treatment‑resistant antibody-mediated neurological diseases such as MS, NMOSD, AE, CIDP, or MG.
-
Nerve function and structure in CMT, anti‑MAG neuropathy, and CIDP
This project will test nerve‑conduction, axonal‑excitability, skin biopsy, and ultrasound measures in adults with CMT, CIDP, or anti‑MAG neuropathy to see if they better describe nerve function and structure.
-
CD19/BCMA-targeted UCAR-T for neurological autoimmune disorders
This trial tests an off-the-shelf CD19/BCMA UCAR-T cell therapy with lymphodepletion in adults with relapsing or treatment-resistant MS, myasthenia gravis, CIDP, or autoimmune encephalitis.
Related topics
Quick answers
How many Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.